Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cytomegalovirus Infection

  Free Subscription


Articles published in Clin Transplant

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    July 2021
  1. JORGENSON MR, Descourouez JL, Leverson GE, Saddler CM, et al
    A Pilot Study of an Intensified Ganciclovir Dosing Strategy for Treatment of Cytomegalovirus Disease in Kidney and/or Pancreas Transplant Recipients.
    Clin Transplant. 2021 Jul 15. doi: 10.1111/ctr.14427.
    PubMed     Abstract available


    June 2021
  2. RHO E, Naf B, Tf M, Rp W, et al
    Use of Letermovir-Valganciclovir combination as a step-down treatment after Foscarnet for Ganciclovir-resistant CMV infection in kidney transplant recipients.
    Clin Transplant. 2021 Jun 28. doi: 10.1111/ctr.14401.
    PubMed     Abstract available


  3. JORGENSON MR, Marka N, Leverson GE, Smith JA, et al
    Valganciclovir Prophylaxis Extension from 3 to 6 Months in High Risk Pancreas Transplant Recipients Does Not Impact Incidence of Cytomegalovirus Infection at 12 months.
    Clin Transplant. 2021 Jun 2:e14379. doi: 10.1111/ctr.14379.
    PubMed     Abstract available


    May 2021
  4. DURST MM, Jorgenson MR, Descourouez JL, Saddler CM, et al
    Bimonthly viral monitoring for late-onset cytomegalovirus infection-Balancing efficacy with patient palatability; A reply to Melgarejo et al.
    Clin Transplant. 2021 May 21:e14348. doi: 10.1111/ctr.14348.
    PubMed    


    March 2021
  5. VEIT T, Pan M, Munker D, Arnold P, et al
    Association of CMV-specific-T-cell immunity and risk of CMV infection in lung transplant recipients.
    Clin Transplant. 2021 Mar 22:e14294. doi: 10.1111/ctr.14294.
    PubMed     Abstract available


  6. RAHIMISHAHMIRZADI M, Jevnikar AM, House AA, Luke PP, et al
    Late-onset Allograft Rejection, Cytomegalovirus Infection and Renal Allograft Loss: Is Anti-CMV Prophylaxis Required Following Late-onset Allograft Rejection?
    Clin Transplant. 2021 Mar 13:e14285. doi: 10.1111/ctr.14285.
    PubMed     Abstract available


    February 2021
  7. MELGAREJO I, Jorgensen D, Hariharan S, Puttarajappa CM, et al
    Bimonthly Viral Monitoring for Late-Onset Cytomegalovirus infection in Kidney Transplant Recipients.
    Clin Transplant. 2021 Feb 19:e14259. doi: 10.1111/ctr.14259.
    PubMed     Abstract available


    January 2021
  8. VON STEIN L, Leino AD, Pesavento T, Rajab A, et al
    Antithymocyte induction dosing and incidence of opportunistic viral infections using steroid-free maintenance immunosuppression.
    Clin Transplant. 2021;35:e14102.
    PubMed     Abstract available


    April 2020
  9. ANDERSON A, Raja M, Vazquez N, Morris M, et al
    Clinical "real-world" experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Clin Transplant. 2020 Apr 3:e13866. doi: 10.1111/ctr.13866.
    PubMed     Abstract available


    March 2020
  10. LAUB MR, Byrns J, Gommer J, Ellis M, et al
    Delayed versus initial cytomegalovirus prophylaxis after kidney transplantation.
    Clin Transplant. 2020 Mar 12:e13854. doi: 10.1111/ctr.13854.
    PubMed     Abstract available


    January 2020
  11. JORGENSON MR, Descourouez JL, Lyu B, Astor BC, et al
    Management of BK Viremia is Associated with a Lower Risk of Subsequent Cytomegalovirus Infection in Kidney Transplant Recipients.
    Clin Transplant. 2020 Jan 29:e13798. doi: 10.1111/ctr.13798.
    PubMed     Abstract available


    November 2019
  12. ASANTE-KORANG A, Carapellucci J, Krasnopero D, Brown B, et al
    Resource Utilization of Cytomegalovirus Immune Globulin in Prevention and Treatment of Cytomegalovirus infection in Pediatric Heart Transplantation.
    Clin Transplant. 2019 Nov 6. doi: 10.1111/ctr.13750.
    PubMed     Abstract available


    August 2019
  13. CRISTELLI MP, Felipe CR, de Souza Prizmic PS, de Azevedo VFD, et al
    Use of mTOR inhibitor as prophylaxis for CMV disease after kidney transplantation: a natural experiment.
    Clin Transplant. 2019 Aug 10. doi: 10.1111/ctr.13689.
    PubMed     Abstract available


    July 2019
  14. GIRMENIA C, Lazzarotto T, Bonifazi F, Patriarca F, et al
    Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: a multidisciplinary consensus conference by the Italian GITMO, SITO and AMCLI societies.
    Clin Transplant. 2019 Jul 16:e13666. doi: 10.1111/ctr.13666.
    PubMed     Abstract available


    June 2019
  15. JORGENSON MR, Descourouez JL, Lyu B, Astor BC, et al
    The Risk of Cytomegalovirus Infection after Treatment of Acute Rejection in Renal Transplant Recipients.
    Clin Transplant. 2019 Jun 13:e13636. doi: 10.1111/ctr.13636.
    PubMed     Abstract available


    March 2019
  16. HEMMERSBACH-MILLER M, Alexander BD, Sudan DL, Pieper C, et al
    Infections after Kidney Transplantation. Does Age Matter?
    Clin Transplant. 2019 Mar 8:e13516. doi: 10.1111/ctr.13516.
    PubMed     Abstract available


    February 2019
  17. RAZONABLE RR, Humar A
    Cytomegalovirus in Solid Organ Transplant Recipients - Guidelines of the American Society of Transplantation Infectious Disease Community of Practice.
    Clin Transplant. 2019 Feb 28:e13512. doi: 10.1111/ctr.13512.
    PubMed     Abstract available


    October 2018
  18. JEWANI PK, Pouch SM, Kissling KT
    Incidence of Cytomegalovirus in Cardiac Transplant Recipients Receiving Induction Immunosuppression with Antithymocyte Globulin.
    Clin Transplant. 2018 Oct 5:e13420. doi: 10.1111/ctr.13420.
    PubMed     Abstract available


    June 2018
  19. HOSSEINI-MOGHADDAM SM, Krishnan RJ, Guo H, Kumar D, et al
    Cytomegalovirus Infection and Graft Rejection as Risk Factors for Pneumocystis Pneumonia in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.
    Clin Transplant. 2018 Jun 29:e13339. doi: 10.1111/ctr.13339.
    PubMed     Abstract available


    April 2018
  20. KNIGHT RJ, Graviss EA, Nguyen DT, Kuten SA, et al
    Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
    Clin Transplant. 2018 Apr 19:e13265. doi: 10.1111/ctr.13265.
    PubMed     Abstract available


    December 2017
  21. SILVA JT, Perez-Gonzalez V, Lopez-Medrano F, Alonso-Moralejo R, et al
    Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: a case series and review of the literature.
    Clin Transplant. 2017 Dec 11. doi: 10.1111/ctr.13176.
    PubMed     Abstract available


    November 2017
  22. BEAM E, Germer JJ, Lahr B, Yao JD, et al
    Cytomegalovirus (CMV) DNA Quantification in Bronchoalveolar Lavage Fluid of Immunocompromised Patients with CMV Pneumonia.
    Clin Transplant. 2017 Nov 7. doi: 10.1111/ctr.13149.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: